1. Clinical efficacy of launched JAK inhibitors in rheumatoid arthritis. (26th February 2019) Authors: Taylor, Peter C Journal: Rheumatology Issue: Volume 58(2019)Supplement 1 Page Start: i17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 076 Assessment of pain improvement in rheumatoid arthritis patients treated with baricitinib, who were inadequate responders to methotrexate and tumor necrosis factor inhibitors. (12th April 2019) Authors: Taylor, Peter C; Fleischmann, Roy; Takeuchi, Tsutomu; Pope, Janet; Genovese, Mark C; Zhu, Baojin; Gaich, Carol; Zhang, Xiang; Dickson, Christina; Quebe, Amanda; Leonardis, Francesco De; Cardoso, Anabela; Kouris, Ilias; Durez, Patrick Journal: Rheumatology Issue: Volume 58(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The Odd Couple?—Hardly. (25th June 2017) Authors: Taylor, Peter C; Jain, Rakesh Journal: Rheumatology Issue: Volume 57:Number 8(2018) Page Start: 1313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 074 Summary of indirect comparison to evaluate efficacy of baricitinib with targeted synthetic and biologic disease anti-rheumatic drugs in patients with rheumatoid arthritis. (12th April 2019) Authors: Emery, Paul; Dudler, Jean; Smolen, Josef; Zerbini, Cristiano; Burmester, Gerd; Fautrel, Bruno; van der Laar, Mart; Fleischmann, Roy; Fakhouri, Walid; Leonardis, Francesco De; Zhu, Baojin; Kadziola, Zbigniew; Torre, Inmaculada De La; Perrier, Clementine; Taylor, Peter C Journal: Rheumatology Issue: Volume 58(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Rheumatoid arthritis and the emergence of immuno-autonomics. (9th June 2019) Authors: Taylor, Peter C; Holman, Andrew J Journal: Rheumatology Issue: Volume 58:Number 12(2019) Page Start: 2079 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Treating to target or treating the patient in rheumatoid arthritis?. (September 2019) Authors: Taylor, Peter C; Pope, Janet Journal: Lancet Issue: Volume 1:Number 1(2019) Page Start: e8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Patient-reported outcome measures in systemic lupus erythematosus by a web-based application: A randomized, crossover, agreement study. (November 2021) Authors: Uhrenholt, Line; Høstgaard, Simone; Pedersen, Julie F; Christensen, Robin; Dreyer, Lene; Leffers, Henrik C B; Taylor, Peter C; Strand, Vibeke; Jacobsen, Søren; Voss, Anne; Gregersen, Jon W; Kristensen, Salome Journal: Lupus Issue: Volume 30:Number 13(2021) Page Start: 2124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety and efficacy of elsubrutinib or upadacitinib alone or in combination (ABBV-599) in patients with rheumatoid arthritis and inadequate response or intolerance to biological therapies: a multicentre, double-blind, randomised, controlled, phase 2 trial. (June 2022) Authors: Fleischmann, Roy; Friedman, Alan; Drescher, Edit; Singhal, Atul; Cortes-Maisonet, Gregorio; Doan, Thao; Lu, Wenjing; Wang, Zailong; Nader, Ahmed; Housley, William; Cohen, Stanley; Taylor, Peter C; Blanco, Ricardo Journal: Lancet Issue: Volume 4:Number 6(2022) Page Start: e395 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A vanA vancomycin-resistant Enterococcus faecium ST80 outbreak resulting from a single importation event. (29th October 2021) Authors: Pratama, Ryanbi; Beukers, Alicia G; McIver, Christopher J; Keighley, Caitlin L; Taylor, Peter C; van Hal, Sebastiaan J Journal: Journal of antimicrobial chemotherapy Issue: Volume 77:Number 1(2022) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated database. Issue 3 (27th October 2021) Authors: Taylor, Peter C; Takeuchi, Tsutomu; Burmester, Gerd R; Durez, Patrick; Smolen, Josef S; Deberdt, Walter; Issa, Maher; Terres, Jorge Ross; Bello, Natalia; Winthrop, Kevin L Journal: Annals of the rheumatic diseases Issue: Volume 81:Issue 3(2022) Page Start: 335 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗